azacitidine and Hemoglobinuria, Paroxysmal

azacitidine has been researched along with Hemoglobinuria, Paroxysmal in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Füreder, W; Gleixner, K; Grünberger, B; Hoermann, G; Kornauth, C; Schwarzinger, I; Sperr, WR; Thalhammer, R; Valent, P	1
Dornaus, S; Frietsch, JJ; Hochhaus, A; Kunert, C; La Rosée, P; Neumann, T; Sayer, HG; Schmidt, V; Scholl, S	1
Berger, EG; Fehr, J; Thurnher, M	1

Reviews

1 review(s) available for azacitidine and Hemoglobinuria, Paroxysmal

Article	Year
Paraneoplastic inflammation in myelodysplastic syndrome or bone marrow failure: case series with focus on 5-azacytidine and literature review. European journal of haematology, 2014, Volume: 93, Issue:3 Topics: Adult; Aged; Anemia, Aplastic; Antimetabolites, Antineoplastic; Autoimmunity; Azacitidine; Bone Marrow; Bone Marrow Diseases; Bone Marrow Failure Disorders; Diagnosis, Differential; Female; Hemoglobinuria, Paroxysmal; Humans; Inflammation; Male; Middle Aged; Myelodysplastic Syndromes; Paraneoplastic Syndromes; Treatment Outcome	2014

Article

Year

Paraneoplastic inflammation in myelodysplastic syndrome or bone marrow failure: case series with focus on 5-azacytidine and literature review.

European journal of haematology, 2014, Volume: 93, Issue:3

Topics: Adult; Aged; Anemia, Aplastic; Antimetabolites, Antineoplastic; Autoimmunity; Azacitidine; Bone Marrow; Bone Marrow Diseases; Bone Marrow Failure Disorders; Diagnosis, Differential; Female; Hemoglobinuria, Paroxysmal; Humans; Inflammation; Male; Middle Aged; Myelodysplastic Syndromes; Paraneoplastic Syndromes; Treatment Outcome

2014

Other Studies

2 other study(ies) available for azacitidine and Hemoglobinuria, Paroxysmal

Article	Year
Major response of PNH to an AML chemotherapy protocol. Annals of hematology, 2018, Volume: 97, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Blast Crisis; Cytarabine; Daunorubicin; Hemoglobinuria, Paroxysmal; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction	2018
Differences in the regulation of specific glycosylation in the pathogenesis of paroxysmal nocturnal hemoglobinuria and the Tn-syndrome. Experimental hematology, 1994, Volume: 22, Issue:3 Topics: Adult; Alleles; Antigens, CD; Azacitidine; Bone Marrow; Butyrates; Butyric Acid; CD48 Antigen; CD8 Antigens; Cells, Cultured; Flow Cytometry; Galactosyltransferases; Gene Expression Regulation, Enzymologic; Glycosylation; Hematologic Diseases; Hemoglobinuria, Paroxysmal; Humans; Leukosialin; Male; Sialoglycoproteins; T-Lymphocytes	1994

Article

Year

Major response of PNH to an AML chemotherapy protocol.

Annals of hematology, 2018, Volume: 97, Issue:8

Topics: Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Blast Crisis; Cytarabine; Daunorubicin; Hemoglobinuria, Paroxysmal; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction

2018

Differences in the regulation of specific glycosylation in the pathogenesis of paroxysmal nocturnal hemoglobinuria and the Tn-syndrome.

Experimental hematology, 1994, Volume: 22, Issue:3

Topics: Adult; Alleles; Antigens, CD; Azacitidine; Bone Marrow; Butyrates; Butyric Acid; CD48 Antigen; CD8 Antigens; Cells, Cultured; Flow Cytometry; Galactosyltransferases; Gene Expression Regulation, Enzymologic; Glycosylation; Hematologic Diseases; Hemoglobinuria, Paroxysmal; Humans; Leukosialin; Male; Sialoglycoproteins; T-Lymphocytes

1994